Any company engaged in developing orphan products or providing services to the pharmaceutical industry would benefit from membership in the NORD Corporate Council. The Council provides a unique opportunity for start-up and established companies to engage with top experts in the rare disease community in addressing topics of mutual interest.
Membership in the Corporate Council reflects your company’s leadership and commitment to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service. The Council provides unique opportunities to engage with NORD’s patient organization members, industry leaders and top scientific, clinical, and policy experts in the worldwide rare disease community.
Specific benefits include:
NORD sponsors two annual meetings and on-going teleconferences. The major areas of focus are policy and regulation, patient access and reimbursement, and research and intelligence. View events >
All companies who join the Council must adhere to the Code of Conduct outlining NORD’s interactions with its corporate members. More >
For more information about the Corporate Council, email email@example.com.